3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide

C26H27FN6O3S — CID 89142612

IUPAC3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide
SMILESCC(C)=NC(=O)c1cccc(CN2CCN(C(=O)c3ccc(NC(=O)Nc4nccs4)c(F)c3)CC2)c1
InChIInChI=1S/C26H27FN6O3S/c1-17(2)29-23(34)19-5-3-4-18(14-19)16-32-9-11-33(12-10-32)24(35)20-6-7-22(21(27)15-20)30-25(36)31-26-28-8-13-37-26/h3-8,13-15H,9-12,16H2,1-2H3,(H2,28,30,31,36)
InChIKeyWPDLPINYRBVOQW-UHFFFAOYSA-N
MW522.61 g/mol
LogP4.51
Rot. Bonds6

About 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide

3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide (PubChem CID 89142612) has the molecular formula C26H27FN6O3S and a molecular weight of 522.61 g/mol. Its IUPAC name is 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide.

Molecular Properties

Compound Name3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide
PubChem CID89142612
Molecular FormulaC26H27FN6O3S
Molecular Weight522.61 g/mol
Exact Mass522.18
IUPAC Name3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide
SMILESCC(C)=NC(=O)c1cccc(CN2CCN(C(=O)c3ccc(NC(=O)Nc4nccs4)c(F)c3)CC2)c1
InChIInChI=1S/C26H27FN6O3S/c1-17(2)29-23(34)19-5-3-4-18(14-19)16-32-9-11-33(12-10-32)24(35)20-6-7-22(21(27)15-20)30-25(36)31-26-28-8-13-37-26/h3-8,13-15H,9-12,16H2,1-2H3,(H2,28,30,31,36)
InChIKeyWPDLPINYRBVOQW-UHFFFAOYSA-N
XLogP4.51
TPSA107.00 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500522.61
LogP ≤ 54.51
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide?
The IUPAC name of 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide (CID 89142612) is 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide.
What is the SMILES notation for 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide?
The canonical SMILES for 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide is CC(C)=NC(=O)c1cccc(CN2CCN(C(=O)c3ccc(NC(=O)Nc4nccs4)c(F)c3)CC2)c1.
What is the InChIKey of 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide?
The InChIKey is WPDLPINYRBVOQW-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H27FN6O3S/c1-17(2)29-23(34)19-5-3-4-18(14-19)16-32-9-11-33(12-10-32)24(35)20-6-7-22(21(27)15-20)30-25(36)31-26-28-8-13-37-26/h3-8,13-15H,9-12,16H2,1-2H3,(H2,28,30,31,36).
What are the key properties of 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide?
3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide has a molecular weight of 522.61 g/mol, XLogP of 4.51, 6 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[4-[3-fluoro-4-(1,3-thiazol-2-ylcarbamoylamino)benzoyl]piperazin-1-yl]methyl]-N-propan-2-ylidenebenzamide is sourced from PubChem (CID 89142612), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).